Abstract: Purpose: To proof the hypothesis that the results achieved by microfracture of the knee in clinical practice are not statistically comparable to those presented in controlled studies. Methods: Our literature search focused on patients with full-thickness cartilage defects of the knee who were treated with microfracture without implantation of a scaffold or injection of substitutes and whose functional capacity was assessed by clinical scores. Whereas these patients formed group A, group B consisted of 26 patients who had been treated at our Level I trauma center. The decision if microfracture was appropriate was made during an arthroscopy of the knee that was scheduled for the repair of meniscal and/or ligamental deficiencies. Due to missing preselection no exclusion criteria were defined. We compared the two groups by performing a correlation analysis. Results: Four randomized controlled trials and one prospective cohort study were detected which provided 187 patients for group A. Surprisingly, a very high correlation (Pearson coefficient r = 0.924, p = 0.008) was calculated between the score values, indicating similar postoperative outcome in both groups. Conclusions: Controlled studies may reflect general population results and therefore provide estimates of treatment effects which are applicable in usual clinical practice.
Introduction


In 1980, microfracture, a single-stage arthroscopic technique, was developed by Steadman [1] . After careful removal of the calcified cartilage layer and after debridement of the lesion until stable cartilage margins are reached, multiple holes are made in the exposed bone with an awl. The resulting tiny fractures ("microfractures") enable bone marrow cells to migrate into the cartilage defect and to create a "super clot" that eventually matures into firm repair tissue. Initially, the efficiency of microfracture was demonstrated for athletes [1, 2] and for traumatic lesions [3] . Due to the good results that had been achieved, the indication for this technique was expanded to degenerative defects [4, 5] 
as well as to
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osteonecrosis [6] . Microfracture provides at least effective short-term improvement of knee function [7] . For this reason and due to its minimally invasive nature, technical ease, limited surgical morbidity, low costs and because it does not prevent the application of other cartilage repair procedures that may be needed in the future, microfracture has gained popularity over the past two decades [8] [9] [10] . It is now a common first-line treatment for patients with cartilage defects of the knee [11, 12] .
Undoubtedly, routinely seen patients who have to be treated surgically often do not correspond with the accurately selected homogenous patient population of a randomized controlled trial. Moreover, the symptoms of a full-thickness cartilage lesion can be superimposed by those of other pathologies like meniscal tears or a rupture of the anterior cruciate ligament. In most cases, the exact extent of the cartilage defect is diagnosed in the operating room during the arthroscopy for the first time and the decision to perform microfracture has to be made spontaneously. Therefore, the goal of our study was to evaluate if the results achieved by microfracture used in clinical practice are statistically comparable to those presented in controlled studies, assuming that they will differ widely.
Method
Literature Search
We searched the electronic databases MEDLINE, EMBASE, CINAHL, and the Cochrane Central Register of Controlled Trials for controlled clinical trials or controlled prospective observational studies. Our literature search was completed on September 1, 2011. As "microfracture" is the generally accepted notation for this technique, we decided to use it as our search term. No language restrictions were applied. We focused on patients who were treated with microfracture without implantation of a scaffold or injection of substitutes and whose functional capacity was assessed by clinical scores. Moreover, our eligibility criteria included full-thickness cartilage defects which were located on the medial or lateral femoral condyle, the trochlea or the patella, caused by acute or repetitive trauma, osteonecrosis or osteochondritis dissecans. The minimum follow-up period was determined to be one year. Two reviewers independently assessed studies for inclusion and evaluated their internal validity. Studies with a high risk of bias were excluded from further analyses and discrepancies were resolved by consensus. All relevant controlled studies detected by our literature search provided the patients summarized as group A. Undoubtedly, the follow-up period plays an important role in outcome evaluation. On the one hand, maximum improvement achieved by microfracture was evaluated during the first two postoperative years [1, 3, [13] [14] [15] [16] , probably as a result of the quantitative and qualitative repair tissue maturation [3, 17, 18] ; on the other hand initial functional improvement started to deteriorate from 18 to 24 months postoperatively [19] [20] [21] [22] [23] [24] . Therefore, the extracted score values of group A should refer to follow-up periods that were comparable to those of our patients. Moreover, an overall evaluation was not possible because score values of one particular patient can vary considerably depending on the chosen system [25] [26] [27] [28] [29] . Therefore, we only combined values to an average which referred to the same clinical score; it was determined to represent the mean score value of group A.
Patients
Group B was formed by 26 patients (19 male, seven female) who had been treated with the microfracture technique at our Level I trauma center. During a follow-up examination these patients agreed to subjectively evaluate their knee by a self-explanatory questionnaire which included eight numerical knee scores as well as the Tegner Score. Only probands were admitted if their surgery had been performed more than twelve months before starting the evaluation. For all patients -all of them were treated by two attending surgeons -an arthroscopy was scheduled for the treatment of meniscal lesions and/or ligament reconstruction. Nevertheless, all patients had been informed about possible additional procedures and associated risks. Therefore, in case of diagnosing a cartilage defect, the decision for microfracture could be taken intraoperatively, if it was considered appropriate by the surgeon. Due to missing preselection no exclusion criteria were defined, resulting in a heterogeneous patient population with an average age of 39.7 (15-63) years, an average BMI of 27 (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) kg/m² and an average follow-up period of 35 (12-67) months. The cartilage lesions classified as grade 3 or 4 according to Outerbridge had an average size of 216 (39-589) mm². 24 patients had focal defects. Of the 28 lesions, five were located on the lateral and 20 on the medial femurcondyle, one was located on the lateral and on the medial tibial plateau each and one was retropatellar. All of the 26 Of all our patients, surgery and rehabilitation protocol were performed as described by Steadman [30] . His therapeutic regimen generally includes the use of a continuous passive motion machine (its impact on the outcome could not be detected [31] ) starting in the recovery room. For lesions on the femoral condyle Steadman insists on crutch-assisted touchdown weight bearing for six to eight weeks, only rarely prescribing a brace, whereas weight bearing as tolerated is allowed for all patients with patellofemoral lesions, but they have to use a brace for at least eight weeks to prevent excessive sheer force on the maturing marrow clot.
Statistical Analyses
For comparison of the results of group A and B in their entirety and not score-by-score we allocated the score values of group A to the relevant score values of group B. In order to identify the degree of linear relationship between the two variables we performed a correlation analysis by calculating the Pearson coefficient. A p-value of 0.01 was assigned as the two-tailed significance level.
Results
Our literature search yielded 1,030 citations (MEDLINE: 391, EMBASE: 514, CINAHL: 105 and Cochrane Register: 20). Four randomized controlled trials [32] [33] [34] [35] [36] and one cohort study [37] , the allocation of patients was determined by health and insurance policy) met our eligibility criteria; these papers are presented in Table 2 . Accordingly, group A consists of 187 surgically treated patients aged between 15 and 60 years (mean 32.4 years) with chondral defects from 1 cm² to 10 cm² of size (mean > 244 cm²), evaluated in a follow-up period of 1 to 5 years. Of all five papers, associated surgery solely referred to anterior cruciate ligament reconstructions and to the treatment of meniscal tears whereas the exclusion criteria (see Table 3 ) varied. In order to achieve comparability to the follow-up period of group B (2.9 years) we used the data evaluated by Gudas et al. and Knutsen et al. one or respectively two years postoperatively, resulting in an average follow-up period of 2.8 years. For outcome evaluation three numerical scores were applied, i.e., the Lysholm [38] and the IKDC Score [39] as well as the KOOS [40] .
Whereas all patients of group A were treated by the microfracture technique as described by Steadman [15] the rehabilitation protocols of the five studies which are presented in Table 4 are not identical to his treatment regimen [30] . Nevertheless, they are similar, not allowing full weight-bearing for four to eight weeks postoperatively.
To be able to compare the two groups statistically we had to assign mean score values to group A at first. For the data presented in Table 5 a correlation analysis was performed by SPSS-18. Of the Pearson coefficient, a value of 0.924 (p = 0.008) was calculated which indicated a very high positive linear correlation [41] between the score values of group A and B. This result was graphically displayed in Fig. 1 .
For every score a number pair was charted in a scatter plot, assigning the relevant score value of group A (variable on the x-axis) to every score value of group B (variable on the y-axis). Fig. 1 
Discussion
According to evidence-based medicine randomized controlled trials (RCT) provide the gold standard for determining the effectiveness of medical interventions [42] . As selection, performance, detection and attrition biases are minimized by randomization the strength of RCTs lies in their internal validity [43] . Due to the fact that treatment groups only differ in the intervention provided to them, differences in observed effects can be attributed to differences in the intervention, resulting in adequate treatment guidelines for clinical practice. Nevertheless, strict exclusion criteria may lead to a population being assessed that is very different to that treated on a daily basis. As a consequence, the question of the external validity of a RCT inevitably arises when its evidence has to be applied to an individual patient [44, 45] . However, the more similar a patient is to those recruited to the trial the more similar results can be expected by applying this treatment to him/her. But in general, the results of randomized controlled trials which refer to the treatment of cartilage defects may not be representative for the general population [46] . Therefore, due to our inhomogeneous patient population we expected results worse than those of the five controlled studies detected by our literature search. Although our correlation analysis revealed statistically comparable results, we must not generalize our findings. They only suggest that outcome achieved by microfracture can, but does not need to be, similar for a homogenous patient population which is presented in controlled studies and for patients in clinical practice to whom no strict predetermined inclusion criteria had been applied. In consequence, controlled studies may reflect general population results and therefore provide estimates of treatment effects which are applicable in daily clinical practice. In consequence, a rough assessment of the expected improvement achieved by microfracture is possible preventing patients from unrealistic expectations.
Limitations of our study include the fact that the number of our patients was very small and that only five number pairs were available for calculating the Pearson correlation coefficient. Nevertheless, we performed the One-Sample Kolmogorov-Smirnov Test which only revealed normal distribution for variable x (p = 0.975). For group B, p = 0.802 was computed.
